Shunichiro Ishikawa

FUJIFILM SonoSite, Inc. engages in the developing, manufacturing and marketing of in hand-carried ultrasound systems, which are used in a variety of medical specialties in a range of clinical settings at the point-of-care. It designs products for applications, including emergency medicine, surgery, critical care, internal medicine, musculoskeletal, and vascular access procedures as well as for imaging in traditional applications, such as radiology, cardiology, vascular medicine and obstetrics and gynecology. The company was founded in April 1998 and is headquartered in Bothell, WA.

Fujifilm Business Innovation Corp. manufactures copying machines, printing systems, publishing systems and digital multifunction machines. Its products include digital color and black and white multifunction devices, document management software, digital color laser printers, digital color scanners, and wide format plotters. The company was founded on February 20, 1962 and is headquartered in Tokyo, Japan.

Part of FUJIFILM Holdings Corp., FUJIFILM Toyama Chemical Co. Ltd. brings innovative solutions to various industries such as healthcare, graphic systems, and digital imaging. The company is based in Tokyo, Japan. The Japanese company's core technologies include chemical, mechanical, optical, electronic, and imaging technologies. With revenues of $21 billion in 2020, the company is committed to responsible environmental stewardship and good corporate citizenship. The company was founded in 1968, and the CEO is Misao Tsuda. FUJIFILM Toyama Chemical Co. was acquired by FUJIFILM Holdings Corp. from Daiichi Sankyo Co., Ltd. on October 01, 2006.

FUJIFILM Corp. engages in the provision of imaging and information solutions. Its offers photography equipment, supplies and services, optical devices, healthcare, high-performance materials, graphic systems, recording media, and industrial products. The company was founded on October 2, 2006 and is headquartered in Tokyo, Japan.

Part of FUJIFILM Holdings Corp., FUJIFILM Diosynth Biotechnologies UK Ltd. is a pharmaceutical manufacturing company. The company is based in Billingham, UK. The British company was founded in 2006. Lars Petersen has been the CEO of the company since 2023.